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Abstract: Modification of host-cell ionic content is a significant issue for viruses,
as several viral proteins displaying ion channel activity, named viroporins, have been
identified. Viroporins interact with different cellular membranes and self-assemble forming
ion conductive pores. In general, these channels display mild ion selectivity, and, eventually,
membrane lipids play key structural and functional roles in the pore. Viroporins stimulate
virus production through different mechanisms, and ion channel conductivity has been
proved particularly relevant in several cases. Key stages of the viral cycle such as virus
uncoating, transport and maturation are ion-influenced processes in many viral species.
Besides boosting virus propagation, viroporins have also been associated with pathogenesis.
Linking pathogenesis either to the ion conductivity or to other functions of viroporins has
been elusive for a long time. This article summarizes novel pathways leading to disease
stimulated by viroporin ion conduction, such as inflammasome driven immunopathology.
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1. Introduction
Cells maintain optimum subcellular compartment ionic conditions, different to those of the
extracellular media by controlling ion transport through lipid membranes. Different cell organelles
present particular ion compositions. These asymmetric distributions of ions among biological
membranes generate electrochemical gradients, essential for the proper cell functioning [1].
Crucial aspects of the cell are governed by the membrane potential, Ca2` stores in the endoplasmic
reticulum (ER) and the Golgi apparatus, and different pH conditions found in the organelles of the
secretory pathway, which benefit from those ion gradients. The coordinate action of a multitude of ion
channels and transporters generates and tightly controls these ionic milieus found within cells.
It is well known that viruses exploit and modify host-cell ion homeostasis in favor of viral infection.
To that purpose, a wide range of viruses encode viroporins [2]. Viroporins constitute a large family
of multifunctional proteins broadly distributed in different viral families, and are mainly concentrated
in RNA viruses [2]. Highly pathogenic human viruses, such as influenza A virus (IAV), human
immunodeficiency virus 1 (HIV-1), hepatitis C virus (HCV), several picornaviruses, respiratory syncytial
virus (RSV), and coronaviruses (CoVs), such as the one responsible for the severe acute respiratory
syndrome (SARS-CoV), and the etiologic agent of Middle East respiratory syndrome (MERS-CoV),
encode at least one viroporin [3–9]. These are transmembrane proteins that stimulate crucial aspects
of the viral life cycle through a variety of mechanisms. Noticeably, these proteins oligomerize in
cell membranes to form ion conductive pores, which generally display mild ion selectivity, indicating
that viroporins do not show preference for particular ionic species. The measurements of channel
conductance are in accordance with the formation of relatively wide pores, supporting the non-specificity
of viroporins. The influence of the lipid charge in channel function is a distinctive feature of some
viroporins, as reported in the case of SARS-CoV E protein [10,11]. Ion channel (IC) activity is relevant
for virus propagation and may have a great impact on host-cell ionic milieus and physiology [2,12,13].
Once inserted on cell membranes, viroporins tune ion permeability at different organelles to stimulate
a variety of viral cycle stages that will be described below. IC activity ranges from almost essential, to
highly or moderately necessary for viruses to yield properly.
Besides modifying cellular processes to favor virus propagation, the loss of ion homeostasis
triggered by viral IC activity may have deleterious consequences for the cell, from stress responses to
apoptosis [2,14,15]. That is why cells have evolved mechanisms to sense the ion imbalances caused
by infections and elaborate immune responses to counteract viruses. Interestingly, the IC activity
of several viroporins triggers the activation of a macromolecular complex called the inflammasome,
key in the stimulation of innate immunity [16–21]. Inflammasomes control pathways essential in
the resolution of viral infections. However, its disproportionate stimulation can lead to disease. In
fact, disease worsening in several respiratory viruses infections is associated with inflammasome-driven
immunopathology [22,23].
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Taking into consideration the relevance of IC activity in viral production, and its direct effect in
pathology and disease, ion conductivity and its pathological stimulated pathways can represent targets
for combined therapeutic interventions.
2. Ion Channels Formed by Viroporins
In general, viroporins are small proteins (less than 100 amino acids) with at least one amphipathic
helix that constitutes its transmembrane domain, spanning lipid membranes [2]. Larger viroporins
have also been described in CoVs. This is the case of SARS-CoV 3a protein, porcine epidemic
diarrhea virus (PEDV) 3 protein, or human coronavirus 229E (HCoV-229E) 4a protein [24–26].
To form the ion conductive pore, viroporins self-assemble and oligomerize, which is a key feature
of this family of proteins. Structural studies for either the transmembrane domain or for full-length
viroporins have revealed the molecular architecture of these viral ion channels, which can present
different oligomerization statuses. IAV M2, picornavirus 2B and Chlorella virus Kcv form tetrameric
structures [27–30], whereas pentamers have been described for HIV-1 Vpu, SARS-CoV and MERS-CoV
E proteins, and RSV SH protein [9,31–34]. HCV p7 and human papillomavirus E5 proteins
form hexameric channels [35,36]. In addition, most measurements of channel conductance are in
accordance with the formation of relatively wide pores, again in agreement with the non-specificity
of viroporins [6,10,37,38].
Ion selectivity of ion channels indicates the preference of the pore for a specific ion and defines
the functional roles that the channel may display. It is known that IAV M2 protein channels are
highly selective for protons and ion conductance is activated at low pH [39–41]. Likewise the IAV
M2 channel, the Kcv protein of Chlorella virus is another highly selective channel, which contains a
conserved K` selectivity filter [29]. Nevertheless, most viroporins usually show mild ion selectivity,
which means that, in general terms, these channels do not display preference for a particular ion. HIV-1
Vpu protein displays a mild cationic selectivity in NaCl and KCl electrolyte solutions [4]. Similarly,
HCV p7 channels are selective for monovalent cations (Na` and K`) over monovalent anions (Cl´) [42].
Moreover, functionally relevant H` transport has also been identified for this protein in cell culture [12].
ORF4a protein of HCoV-229E forms a channel that prefers cations over anions but does not show a clear
specificity for a particular type of cation [25]. Still, a lot of electrophysiology experiments remain to be
done for a proper characterization of viroporin selectivity. Setting aside a few highly proton selective
viroporins, the vast majority display a weak selectivity, either cationic or anionic, which is strongly
dependent on the lipid charge of their host membrane, as discussed below in detail.
Interestingly, under some circumstances the selectivity of these channels can be modulated. SH
protein exhibits a poor cationic selectivity at neutral pH, which turns into anionic at acidic pH [43].
This is consistent with the titration of histidines, the only titratable residues of the SH protein. The
presence of Ca2` in selectivity experiments performed in KCl solutions reduced the cationic preference
of p7 channels, which may indicate that Ca2` affect the selectivity filter [42]. Probably, the most striking
mechanism influencing IC selectivity and conductance has been recently reported for SARS-CoV E
protein [10,11]. It was observed that the lipids are an integral component of the pore structure because
electrophysiological measurements proved that the lipid charge modulates the ion transport properties
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of the SARS-CoV E protein. These findings suggested that viroporins can assemble into alternative
complex structures, forming protein-lipid pores (Figure 1).Viruses 2015, 7 4 
 
 
Figure 1. Ion channels formed by viroporins. Left depiction represents a channel exclusively 
formed by protein monomers (blue cylinders) inserted on a lipid membrane. Schematic on 
the right shows a protein-lipid pore. In this latter case, the lipid head groups (cyan circles) 
are oriented towards the channel pore, modulating ion conductance and selectivity. 
The IC activity of a number of transmembrane proteins, as well as of small peptides and antimicrobial 
peptides, is strongly dependent on the lipid environment. The case of SARS-CoV E protein is a clear 
example of how lipid membrane charge influences the main ion transport properties of an IC. E protein 
behaves quite differently when reconstituted in neutral or negatively-charged membranes (Figure 2). 
 
Figure 2. Functional involvement of lipid head groups in the protein-lipid pore formed by 
SARS-CoV E protein. Depictions represent E protein channels inserted in non-charged 
membranes (left) or negatively-charged membranes (right), under low solute concentrations 
and neutral pH. In these circumstances, each E protein monomer presents two negative 
charges provided by glutamic acid residues, and a positive charge conferred by an arginine. 
When reconstituted in fully or partially negatively-charged membranes, lipid head groups 
provide additional negative charges to the pore, which makes E protein channel more 
selective for cations and more conductive. 
Conductance experiments showed that in non-charged phosphatidylcholine membranes, the E protein 
channel acts as a non-selective neutral pore, since the channel conductance changes linearly with bulk 
solution conductivity [11]. In contrast, in negatively charged phosphatidylserine membranes the 
variation of channel conductance with solution concentration follows different regimes depending on 
the salt concentration; a characteristic trait of charged pores [10,11,44]. These experiments, together 
with ion selectivity measurements [11], suggest that E protein behaves as a charged pore in negatively-
charged membranes. Parallel observations are made when reconstituting SARS-CoV E protein in 
membranes containing a small percentage of charged lipids and, in particular, in membranes containing 
Figure 1. Ion channels formed by viroporins. Left depiction represents a channel exclusively
formed by protein monomers (blue cylinders) inserted on a lipid membrane. Schematic on
the right shows a protein-lipid pore. In this latter case, the lipid head groups (cyan circles)
are oriented towards the channel pore, modulating ion conductance and selectivity.
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Figure 2. Functional involvement of lipid head groups in the protein-lipid pore formed
by SARS-CoV E protein. Depictions represent E protein channels inserted in non-charged
membranes (left) or negatively-charged membranes (right), under low solute concentrations
and neutral pH. In these circumstances, each E protein monomer presents two negative
charges provided by glutamic acid residues, and a positive charge conferred by an arginine.
When reconstituted in fully or partially negatively-charged membranes, lipid head groups
provide additional negative charges to the pore, which makes E protein channel more
selective for cations and more conductive.
acts as a non-s lective neutral pore, since the channel condu tance changes linearly with
bulk solution conductivity [11]. In contrast, in negatively charged osphatidylserin membranes
the variation of channel conductance with solution o centration follows different regimes depe ding
on the salt concentration; a haracterist c trait of charg d pores [10,11,44]. These experim nts,
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together with ion selectivity measurements [11], suggest that E protein behaves as a charged pore
in negatively-charged membranes. Parallel observations are made when reconstituting SARS-CoV E
protein in membranes containing a small percentage of charged lipids and, in particular, in membranes
containing the same amount of charged lipid („20%) as the ERGIC-Golgi membranes, where E protein
channel is presumably localized [10]. These observations support the view that some polar lipid
heads line the pore lumen together with the protein transmembrane helices and that both, protein and
lipids, contribute to channel selectivity. An additional proof reinforcing this hypothesis is provided
by electrophysiology experiments using lipids with negative intrinsic curvature. It is known that the
protein-lipid pore formation is favored in membranes with positive curvature [45]. In fact, when E
protein is reconstituted in dioleoyl phosphatidylethanolamine membranes, a lipid with intrinsic negative
curvature, it is much more difficult to achieve channel insertion because the membrane negative
curvature becomes energetically unfavorable for the assembly of a proteolipidic structure [10]. The E
protein-lipid channel may not constitute a unique case, as poliovirus 2B permeabilization displayed a
strict requirement for anionic phospholipids in the membrane composition [28], which may indicate that
lipid molecules are involved in the pore formation.
Regulatory mechanisms, such as gating, operate in some viroporins. Histidine residues present in
the IAV M2 transmembrane domain become protonated when encountering low pH conditions, and
experience a conformational change that opens the channel pore allowing H` flux [46]. The influence
of the histidine residues in the IC is also observed in the SH protein. In this protein the conductance is
pH-dependent and consistent with the titration of these residues [43].
Viroporins could be regulating the transport capacity of cellular ion transporters, besides showing their
intrinsic IC activity. A well-defined case is that of human papillomavirus oncoprotein E5, which interacts
with vacuolar H` ATPase (V-ATPase) modulating its function and leading to cell transformation [47,48].
Interestingly, other viroporins interact with cellular ion pumps. SARS-CoV E protein binds the alpha
subunit of Na`/K` ATPase in infected cells [49]. IAV M2 protein binds Na`/K` ATPase beta1
subunit [50]. It is well known that the ion transport capacity of cellular pumps such as Na`/K` ATPase
and sarcoendoplasmic reticulum Ca2` ATPase (SERCA) may be influenced by the interaction with other
proteins. FXYD proteins and phospholamban are well-characterized examples [51,52]. These regulatory
proteins are small transmembrane proteins that oligomerize and eventually form ICs when reconstituted
in artificial lipid membranes [53], as happens for viroporins. Some examples of viroporins modifying
the activity of cellular ion channels have also been reported. HIV-1 Vpu interacts with the K` channel
TASK-1 promoting viral release [54]. In addition, indirect inhibition of epithelial sodium channels has
been reported for IAV M2 and SARS-CoV E proteins [55,56]. The possibility of a dual role of ion
modulation by viroporins, depending both on their intrinsic transport properties and on their possible
regulatory activity on key cellular ion transporters, increases the potential relevance of this family
of proteins.
3. Ion Channel Activity and Virus-Host Interaction
3.1. Virus Production
Viroporins are involved in processes relevant for virus production. In general, these proteins do not
affect viral genome replication, but stimulate other key aspects of the viral cycle such as entry, assembly,
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trafficking and release of viral particles [2,13]. As a consequence, partial or total deletion of viroporins
usually leads to significant decreases in viral yields. HCV p7 viroporin is indispensable for virus
propagation, as no infectious viruses are recovered when p7 protein is eliminated [57]. Other viruses
are more tolerant to viroporin deletion. Thus, IAV or HIV-1 lacking M2 and Vpu, respectively, can
be efficiently rescued. Nevertheless, in general, viroporin defective viruses show significantly lower
virus yields, ranging from 10- to 100-fold [58,59]. The relevance of E viroporin in coronavirus
production seems to be species-specific. Deletion of E gene in transmissible gastroenteritis virus (TGEV)
and MERS-CoV generates replication-competent propagation-deficient viruses [60,61]. E gene is not
essential for virus production in SARS-CoV and mouse hepatitis virus (MHV), although in its absence
viral titters are reduced from 100- to 1000-fold, respectively [62,63]. Silencing of SARS-CoV 3a
protein, PEDV 3 protein, and HCoV-229E 4a protein expression in virus infection cause a reduction
in virus titers [24,25,64], supporting that these viroporins are involved in virus production. In the case of
SARS-CoV 3a protein, this has also been shown in mice infected with a SARS-CoV variant missing 3a
protein (C. Castaño-Rodriguez, J.L. Nieto-Torres and L. Enjuanes, unpublished results). In some cases,
viroporin deletion induces a growth restriction that can be cell or tissue specific. Thus, RSV lacking the
SH gene, shows an efficient growth in cell culture, but a limited production in the nasal turbinates of
infected mice or chimpanzees, as compared with the wild type virus [65,66].
Collectively, previous data support that viroporins stimulate virus propagation. A key issue is to
understand the relevance of their IC conductance on this activity. Both viroporin IC activity and other
functions not related to ion conductivity apparently affect virus propagation. Some non-conductive
viroporin domains are important players in viral morphogenesis. The cytoplasmic tail of several
viroporins actively participates in virus production. A few examples are now briefly described. CoV E
protein C-terminal domain interacts with the viral membrane (M) protein during the morphogenesis
process [67]. In fact, the last nine amino acids of SARS-CoV E protein C-terminus stimulate virus
growth [68]. This protein sequence includes a PDZ-binding motif involved in interactions with cellular
proteins and virulence. IAV M2 cytoplasmic domain interacts with the M1 protein to favor virus
assembly at the site of budding [69]. An amphipathic helix located in the cytoplasmic tail of the
IAV M2 protein induces bending of cellular membranes, necessary for budding, and excision of the
nascent particles [70]. This functional domain works independently to the M2 ion conductive properties.
HIV-1 Vpu also facilitates budding termination of newly formed viruses in an IC independent manner.
Vpu deleted viruses are less efficiently released and remain attached to the plasma membrane of infected
cells [59]. In this case, the transmembrane domain of Vpu accounts for this phenotype by establishing
critical interactions with cellular proteins such as one with the interferon-stimulated protein tetherin.
This binding prevents tetherin from inhibiting the release of viral particles at the plasma membrane of
infected cells [71,72]. Both IC activity and tetherin inhibitory property are concentrated in the Vpu
transmembrane domain, nevertheless these functions work independently [73].
Accumulating reports support that viroporin ion conductivity favors virus yields. Inhibition of
viroporin IC properties, through subtle mutations that may not interfere with other functions of the
protein, affects viral growth to different extents. Point mutations that blocked HCV p7 IC activity either
completely abrogated virus production or resulted in a 100-fold restriction in virus yields, depending
on the virus strain [12,57]. Influenza viruses lacking M2 ion conductivity, presented either a 15-fold
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reduction of viral titer in tissue culture [74], or showed a standard production in cell culture but a
restricted growth in the nasal turbinates of infected mice [75]. SARS-CoV E protein ion conductivity
also supports viral production and fitness. E protein IC activity was knocked down by introducing
point mutations in key residues of its transmembrane domain [10]. Although not essential for virus
production, E protein IC activity stimulated viral propagation. Viruses lacking E protein ion conductivity
were outcompeted by others displaying this function [22]. In fact, IC defective viruses tended to restore
ion conductance by introducing compensatory mutations in the transmembrane domain of the protein
both in cell cultures and in mice [22]. In agreement with these data, IAV lacking M2 IC activity
showed fitness defects, as it was outgrowth by the parental virus, in an even faster manner than that
observed in SARS-CoV [74]. The relevance of ion conductivity in boosting virus production remains
unknown for the moment in other viral systems. Initial findings argued that scrambling of the HIV-1
Vpu transmembrane domain inactivated ion conductivity and partially inhibited viral production [76].
However, this alteration of the transmembrane domain affected the Vpu-tetherin interaction and IC
activity. Recent reports showed that mutations that specifically inhibited ion conductivity, but not
Vpu-tetherin interaction, did not affect VLP production; therefore, this interaction with tetherin seems
to be responsible for the observed phenotype [73].
Pharmacological inhibition of viroporin ion conductance further supports the role of IC in virus
propagation. Several compounds inhibit viroporin ion conductivity in artificial lipid membranes, and
some of them efficiently reduce viral growth when administered to infected cells. Inhibition of M2
protein IC activity mediated by amantadine prevents or decreases viral growth in a strain specific
manner [39,77]. Amantadine also inhibits HCV growth [13]. HCoV-229-E and MHV growth is restricted
by hexamethylene amiloride, which blocks E protein ion conductivity [78]. The viral growth inhibitory
properties of these compounds encourage its use as potential antivirals. This aspect will be further
addressed below.
Widely conserved pathways influenced by viroporin ion conductivity, and others that seem to be
species-specific are now described and graphically summarized to facilitate their overview (Figure 3).
3.1.1. Viral Entry
Early key aspects of virus cycle, such as viral entry, can be boosted through ion conductivity.
Non-enveloped viral particles lack viroporins as structural components, and these proteins are poorly
represented in the membrane of enveloped viruses [63,79–81]. Nevertheless, the viroporin molecules
embedded in the viral envelope can actively participate in viral entry; IAV M2 protein is a well
characterized example. IAV is internalized within the cell through an endocytic process. Endosomes
containing viral particles fuse with acidic organelles to form endolysosomes. The H` ATPase of these
organelles pumps H` inside their lumen lowering the pH. The few M2 copies present in the IAV envelope
are activated by the low pH conditions and allow the flux of H` inside the viral particle. The acidification
of the endocytosed virion drives a series of conformational changes in the viral hemagglutinin (HA)
protein, leading to the exposure of a fusion peptide [82,83]. In parallel, the M1 protein layer, which
underlies the viral envelope, and protects the viral ribonucleoproteins, is disassembled under these pH
conditions [84]. The fusion peptide finally triggers the fusion of the viral and endosomal membranes,
resulting in the release of viral ribonucleoproteins in the cell cytoplasm. Inhibition of M2 protein
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IC activity by amantadine results in incomplete uncoating of the virion in some IAV strains [39,77].
This mechanism does not seem relevant for HCV virus, as its entry is independent of p7 IC activity [12].
Whether or not this pathway, or related ones, participate in the entrance of other viral species remains to
be established.Viruses 2015, 7 8 
 
  
Figure 3. Pathways stimulated by viroporin ion channel activity leading to virus production. 
Viral-membrane embedded viroporins (red ellipses) transport H+ inside the endocytosed 
virion. This causes structural changes in fusion and matrix proteins facilitating the uncoating 
of viral ribonucleoproteins (1); Viroporin-mediated ions leak from intracellular organelles 
such as the endoplasmic reticulum (ER) or the Golgi apparatus towards the cytoplasm causes 
a blockade of vesicle transport and/or hijacking of autophagic membranes. These processes 
finally result in the accumulation of membranous structures that will serve as platforms for 
viral replication and morphogenesis. Blue, red and green structures show the viral replicase 
(2); In addition, equilibration of Golgi and secretory pathway organelles’ pH protect both 
viral proteins involved in entry (blue structures and green ellipses) and newly formed virions 
that can be sensitive to acidic environments (3); Viroporins (red and blue ellipses), locate in 
the budding neck of some enveloped viruses. These proteins may interact and oligomerize, 
rearranging the formation of channels, which additionally could facilitate virion scission (4). 
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Figure 3. Pathways stimulated by viroporin ion channel activity leading to virus production.
Viral-membrane embedded viroporins (red ellipses) transport H` inside the endocytosed
virion. This causes structural changes in fusion and matrix proteins facilitating the uncoating
of viral ribonucleoproteins (1); Viroporin-mediated ions leak from intracellular organelles
such as the endoplasmic reticulum (ER) or the Golgi apparatus towards the cytoplasm causes
a blockade of vesicle transport and/or hijacking of autophagic membranes. These processes
finally result in the accumulation of membranous structures that will serve as platforms for
viral replication and morphogenesis. Blue, red and green structures show the viral replicase
(2); In addition, equilibration of Golgi and secretory pathway organelles’ pH protect both
viral proteins involved in entry (blue structures and green ellipses) and newly formed virions
that can be sensitive to acidic environments (3); Viroporins (red and blue ellipses), locate in
the budding neck of some enveloped viruses. These proteins may interact and oligomerize,
rearranging the formation of channels, which additionally could facilitate virion scission (4).
3.1.2. Remodeling of Cell Organelles
Modification of the ionic content of intr cellular compartments can ultimately result in functional
and morphological transformations. The ion conductivity of several viroporins aff cts protein transport.
Alteration of the ionic content of the Golgi apparatus and the endosomes interfere with cellular protein
processing and sort ng [85]. IAV M2 c uses a lag in protein transport through the Golgi apparatus [86].
This d lay on transport can be inhibited by e addition of amantadine, an IC activity inhibitor of
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M2 protein. Furthermore, monensin, an H`/Na` antiporter, causes similar defects. Both M2 and
monensin induce dilation of Golgi cisternae, although to different extents. Infectious bronchitis virus
(IBV) E protein also affects protein transport through the secretory pathway, whereas the mutant
predicted to inhibit IC activity does not [87]. Coxsackievirus 2B protein disturbs pH and calcium
homeostasis in the Golgi and the ER, thereby inhibiting protein transport. Mutations inhibiting 2B ion
conductivity restored proper protein trafficking [88]. Ca2` is involved in membrane fusion events, and
its leakage to the cell cytoplasm causes anterograde vesicle trafficking blockage. SARS-CoV 3a protein
is both necessary and sufficient for SARS-CoV Golgi fragmentation and promotes the accumulation of
intracellular vesicles that may be used for virus formation or for non-lytic release of virus particles [89].
The exact relevance of protein transport delay on virus production remains to be established. It has
been speculated that alteration of ionic homeostasis in transport vesicles affects anterograde trafficking
leading to conglomeration of cell membranes that will serve as the platforms for viral replication and
budding [88]. In addition, ionic efflux from intracellular organelles can lead to pathways triggering the
accumulation of autophagic vacuoles as platforms for virus replication. In fact, rotavirus nsp4 viroporin
allows Ca2` efflux form ER thereby triggering autophagy in favor of viral infection [90].
3.1.3. Protection of the Viral Progeny
In many cases, viral proteins, and even virions, have to progress through the secretory pathway,
encountering the low pH found within the Golgi apparatus lumen [91]. These acidic conditions may
inactivate forming virions, which eventually are acid-sensitive [12]. Viroporin ion conductivity is critical
in viral progeny protection and, occasionally, it can be trans-complemented by heterologous viroporins.
IAV M2 IC activity is thought to keep the pH of the Golgi apparatus and its associated vesicles above a
threshold, in order to avoid conformational changes in HA which may lead to its premature activation
rendering non-infectious viruses. In fact, blocking of M2 ion conductivity by amantadine induces
irreversible activation of HA [92]. This effect can be overcome by the treatment of infected cells
with monensin that alkalizes the Golgi in an analogous manner to M2 protein. Similarly to what has
been shown for M2 protein, HCV p7 protein mediates a H` leak from intracellular organelles, and this
alkalinization is required for the production of infectious viruses [12]. Mutant viruses lacking p7 ion
conductivity were not rescued, and treatment with amantadine greatly diminished the production of wild
type infectious virions. Furthermore, in the absence of p7 IC activity, alternative approaches to balance
the pH of intracellular organelles result in partial recovery of infectious viruses. Either Bafilomycin A1
treatment, an inhibitor of a H` vacuolar ATPase (V-ATPase), or expression of IAV M2, but not the M2
IC mutant, rescued virus production [12].
3.1.4. Release of Newly Formed Virions
The increase of cellular permeability by viroporins, IC activity may ultimately result in cell lysis,
a requisite for the egress of non-enveloped viruses [2]. It has also been speculated that disruption of
ion gradients may trigger the membrane fusion events necessary for budding termination and release of
enveloped viruses [2]. Nevertheless, in the latter case other non-ion conductive viroporin functions, as
those previously described for M2 and Vpu, may also be relevant in the release process. In addition, we
propose that viroporins, located in the budding neck of forming viruses [70], could oligomerize to form
an IC facilitating membrane fusion and budding termination.
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3.2. Pathogenesis
Besides their key role in virus propagation, viroporins are also virulence factors in different viral
systems. Total or partial deletion of non-essential viroporins usually leads to attenuated phenotypes.
Interestingly, these viroporin-deleted viruses have been successfully used as potential vaccine candidates.
Mice infected with an IAV lacking M2 protein showed no weight-loss, nor pathology, and were
protected against the wild type virus [93]. An RSV defective for SH protein showed growth
attenuation in the upper respiratory tracts of mice and chimpanzees and caused mild disease [65,66].
A classical swine fever virus (CSFV) missing full-length or partial-length p7 protein, similar to HCV
p7 viroporin, lacked virulence [94]. A SARS-CoV lacking the full-length E protein (SARS-CoV-∆E)
was attenuated in hamsters, transgenic mice expressing the human SARS-CoV receptor (hACE2), and
in both young and elderly mice. SARS-CoV-∆E induced increased stress and limited NF-κB driven
inflammation [62,95,96]. In addition, elimination of defined E protein regions of 6–12 amino acids in
its carboxy-terminus leads to viral attenuation [68,97]. Several of these mutants are promising potential
vaccine candidates for SARS-CoV. SARS-CoV 3a protein regulates host-cellular responses involved in
the activation of pro-inflammatory genes such as C-Jun and NF-κB [98–100], and in the production of
pro-inflammatory cytokines and chemokines such as IL-8 or CCL5 [99]. Furthermore, 3a protein IC
activity has been linked to its pro-apoptotic function [101]. PEDV 3 protein has also been involved in
pathogenesis as a PEDV with a 49-nucleotide deletion in 3 gene lacks IC activity and is attenuated [24].
Viroporins are frequently associated with virus propagation, as their deletion from the viral genome
usually causes viral titer drops that, by themselves, could contribute to the attenuated viral phenotype.
However, viroporin removal can modulate cellular signaling pathways leading to virulence. It has
been proposed that the protein transport blockage exerted by the IC activity of viroporins, such as
that from coxsackievirus 2B and coronavirus E proteins causes a delay in the transport of major
histocompatibility complex class I (MHC-I) molecules towards the plasma membrane [87,88,102].
This MHC-I trafficking defect allows the evasion of adaptive immune responses, leading to more
productive infections (Figure 4).
Over stimulation of immune responses can also lead to pathogenesis. Indeed, IC activity is an
important trigger of immunopathology, as demonstrated for SARS-CoV E protein. Mutant viruses
lacking ion conductivity, which showed proficient replication in mice lungs, presented an attenuated
phenotype. Animals infected with the SARS-CoVs lacking E protein IC activity showed a reduced
mortality in comparison with those inoculated with the parental virus [22]. Interestingly, mice infected
with the IC defective viruses presented much less edema accumulation in the lung airways, the ultimate
cause of acute respiratory distress syndrome (ARDS) [103]. Flooded bronchioles and alveoli fail
to interchange gases, leading to hypoxemia and eventually to death. Noticeably, there was a good
correlation between edema accumulation and the disassembly of the airway epithelia which, when
intact, drive edema resolution through an ion mediated water reabsorption. Edema accumulation and
airway epithelia damage is accompanied by an exacerbated proinflammatory response in the lung
parenchyma [103]. Animals infected with the IC deficient viruses presented decreased levels of IL-1β,
TNF and IL-6 in the lung airways, key mediators of the ARDS progression. IL-1β is a key orchestrator
of the inflammatory response and plays a critical role in counteracting invading viruses, however
overstimulation of this pathway can lead to unwanted deleterious effects for the organism. In fact, over
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production of IL-1β is related with important pathologies such as gout, atherosclerosis, diabetes, ARDS
and asthma [104–107]. As a consequence, IL-1β production is tightly regulated in the organism, through
the inflammasome multiprotein complex.
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Figure 4. Pathways stimulated by viroporin ion channel activity leading to pathology.
Molecular patterns associated with viral infections are recognized by cellular sensors (signal
1), which activate the transcription and translation of the NLRP3 inflammasome components
(NLRP3, ASC and procaspase-1) and the inactive pro-IL-1β. Viroporins inserted in the
intracellular organelles, such as the endoplasmic reticulum (ER) or the Golgi apparatus,
favor the leak of Ca2` and H` ions that move following their electrochemical gradient into
cell cytoplasm. This ionic imbalance (signal 2) induces the assembly of the inflammasome
complex, which triggers the maturation of pro-IL-1β into IL-1β through the action of
caspase-1. Secreted IL-1β mediates a potent pro-inflammatory response that can be
deleterious for the cell and the organism, when overstimulated. In addition, alteration of ionic
milieus in intracellular compartments comes along with a protein transport delay or blockage.
This results in a decrease of the levels of MHC-I molecules (blue rectangles) at the plasma
membrane, preventing the infected cell to be recognized by the immune system. Protein
transport blockage also diminishes the levels and activity in the cell surface of ion channels
and transporters, crucial in the resolution of edema accumulation. Epithelial sodium
channels (green structure) and Na`/K` ATPase (purple rectangles) impairment have been
related to the worsening of viral respiratory diseases such as those caused by SARS-CoV,
IAV or RSV.
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How can viral IC activity stimulate this exacerbated inflammatory response leading to pathology
and disease? Inflammasomes participate in pathogen recognition by sensing disturbances in cellular
milieus, including intracellular ionic concentrations [108,109]. The NLRP3 inflammasome is one
of the most extensively studied [110]. Two signals are generally required to activate this complex:
the first one is usually triggered by molecular patterns associated to the viral infection, such as
double-stranded RNA. This leads to the transcription and translation of the different components of
the inflammasome and the immature pro-IL-1β [16]. Only when a second signal is simultaneously
present, the components of the inflammasome are assembled, leading to the cleavage and activation of
caspase-1. This protein processes pro-IL-1β into its active form IL-1β that is released to the extracellular
media to promote proinflammation [16]. Interestingly, viroporin IC activity represents the second signal
required for inflammasome activation, inducing the release of active IL-1β (Figure 4). In general,
viroporins induce an efflux of ions, such as H` and Ca2` that move from their intracellular stores
into the cytoplasm following strong electrochemical gradients, triggering the NLRP3 inflammasome.
IAV M2 was the first noticed ion conducting viral protein activating this pathway [16]. Nowadays,
several other viroporins stimulating the inflammasome have been identified. RSV SH, human
rhinovirus 2B, encephalomyocarditis virus 2B, HCV p7, and IAV PB1-F2, among others, are additional
examples [17–20,23,111]. This mechanism of overstimulation of IL-1β production seems to have key
consequences in pathogenesis. The severity of human rhinovirus infection is linked to overinflammation
and release of cytokines, including IL-1β. Rhinovirus 2B protein causes a Ca2` leakage from the ER
and Golgi apparatus essential for inflammasome activation and IL-1β production [19]. Similarly, RSV
SH activates this pathway resulting in immunopathology [18].
Given the wide variety of effects that viroporin IC activity has on viral propagation and its influence
on pathogenesis, inhibition of IC conductivity has been a promising target for therapeutic interventions.
A growing list of compounds interfering with viroporin IC activity of several viruses such as IAV,
HCV, HIV-1, coronaviruses, and RSV, has been described [43,78,112–114]. Despite being active in
artificial lipid bilayers, and sometimes in cell culture, the pharmacological use of antagonists of IC
activity in humans is still limited to a reduced number of cases. Amantadine was the first inhibitor of
viroporin IC activity approved for use in humans, and it has been utilized in clinics for around 20 years
in the treatment of IAV [113]. Amantadine binds M2 protein at the N-terminal lumen of the channel
and at the C-terminal surface of the protein with high and low affinities, respectively, blocking ion
conductance and interfering with viral replication [115]. However, IAV variants containing mutations in
the M2 transmembrane domain that conferred resistance to amantadine emerged [115,116]. Amantadine
and hexamethylene amiloride are effective inhibitors of HCV p7 IC activity as shown using in vitro
systems [42,112]. HCV shows a genotype-dependent sensitivity to amantadine, when the drug is applied
at high doses, which may explain its inefficacy in infected patients, limiting the application of amantadine
in HCV disease treatment [117]. Similarly, high concentrations of hexamethylene amiloride are required
to inhibit p7 conductivity in cell culture, which increased its toxicity, making this drug unsuitable for
clinical administration [117]. However, drug screenings have identified other promising compounds
interfering p7 IC activity, such as long alkyl iminosugars derivatives and BIT225, with the latter showing
modest but successful restriction of HCV load in infected patients [6,118]. These compounds may
represent the basis for a therapeutic treatment of hepatitis C.
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Taking into consideration the fast selection of drug-resistant viruses under drug pressure, the
simultaneous inhibition of IC activity, and other signaling pathways stimulated by ion conductivity
leading to pathology, may represent a better treatment option. Interfering with these pathological
pathways constitutes a valuable approach, with the advantage that it is independent of the appearance
of drug resistant viruses. Targeting exacerbated inflammatory responses, such as those triggered by
IC activity leading to inflammasome activation in various respiratory infections, may reduce disease
worsening and progression [23]. Novel specific inhibitors of NLRP3 inflammasome showing promising
results for inflammatory diseases could be applied for these purposes [119].
4. Summary and Future Prospects
Viroporins have been known for a long time as key contributors to virus propagation and stimulators
of pathogenesis. Several reports have dissected the crucial impact that IC activity has in these processes.
It is remarkable how these small channels have high implications at the cell level favoring virus
production and, at the same time, causing disturbances at a tissue or organism level eventually leading to
pathology. Understanding the molecular and physicochemical structure of these ion pores may constitute
the basis for rational design of specific IC activity inhibitors and strategies to counteract the pathology
mediated by IC activity.
Acknowledgments
The work done by the authors was supported by grants from the government of Spain
(BIO2013-42869-R, FIS2013-40473-P), Generalitat Valenciana (Prometeo 2012/069), Fundació Caixa
Castelló-Bancaixa (P1-1B2012-03) and a U.S. National Institutes of Health (NIH) project
(5P01AI060699). JLN-T received a contract from NIH. CC-R received a contract from Fundacion
La Caixa.
Author Contributions
Jose L. Nieto-Torres, Carmina Verdiá-Báguena, Carlos Castaño-Rodriguez, Vicente M. Aguilella and
Luis Enjuanes, wrote and revised the manuscript. Jose L. Nieto-Torres and Carmina Verdiá-Báguena
illustrated the figures.
Conflicts of Interest
The authors declare no conflict of interest.
References
1. Dubyak, G.R. Ion homeostasis, channels, and transporters: An update on cellular mechanisms.
Adv. Physiol. Educ. 2004, 28, 143–154. [CrossRef] [PubMed]
2. Nieva, J.L.; Madan, V.; Carrasco, L. Viroporins: Structure and biological functions. Nat. Rev.
Microbiol. 2012, 10, 563–574. [CrossRef] [PubMed]
Viruses 2015, 7 3565
3. De Jong, A.S.; Visch, H.J.; de Mattia, F.; van Dommelen, M.M.; Swarts, H.G.; Luyten, T.;
Callewaert, G.; Melchers, W.J.; Willems, P.H.; van Kuppeveld, F.J. The coxsackievirus 2B protein
increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein
trafficking through the Golgi. J. Biol. Chem. 2006, 281, 14144–14150. [CrossRef] [PubMed]
4. Ewart, G.D.; Sutherland, T.; Gage, P.W.; Cox, G.B. The Vpu protein of human immunodeficiency
virus type 1 forms cation-selective ion channels. J. Virol. 1996, 70, 7108–7115. [PubMed]
5. Henkel, M.; Mitzner, D.; Henklein, P.; Meyer-Almes, F.J.; Moroni, A.; Difrancesco, M.L.;
Henkes, L.M.; Kreim, M.; Kast, S.M.; Schubert, U.; et al. The proapoptotic influenza A virus
protein PB1-F2 forms a nonselective ion channel. PLoS ONE 2010, 5, e11112. [CrossRef]
[PubMed]
6. Pavlovic, D.; Neville, D.C.; Argaud, O.; Blumberg, B.; Dwek, R.A.; Fischer, W.B.; Zitzmann, N.
The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain
iminosugar derivatives. Proc. Natl. Acad. Sci. USA 2003, 100, 6104–6108. [CrossRef] [PubMed]
7. Pinto, L.H.; Holsinger, L.J.; Lamb, R.A. Influenza virus M2 protein has ion channel activity. Cell
1992, 69, 517–528. [CrossRef]
8. Wilson, L.; McKinlay, C.; Gage, P. SARS coronavirus E protein forms cation-selective ion
channels. Virology 2004, 330, 322–331. [CrossRef] [PubMed]
9. Surya, W.; Li, Y.; Verdia-Baguena, C.; Aguilella, V.M.; Torres, J. MERS coronavirus envelope
protein has a single transmembrane domain that forms pentameric ion channels. Virus Res. 2015,
201, 61–66. [CrossRef] [PubMed]
10. Verdia-Baguena, C.; Nieto-Torres, J.L.; Alcaraz, A.; Dediego, M.L.; Torres, J.; Aguilella, V.M.;
Enjuanes, L. Coronavirus E protein forms ion channels with functionally and structurally-involved
membrane lipids. Virology 2012, 432, 485–494. [CrossRef] [PubMed]
11. Verdia-Baguena, C.; Nieto-Torres, J.L.; Alcaraz, A.; Dediego, M.L.; Enjuanes, L.; Aguilella, V.M.
Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge.
Biochim. Biophys. Acta 2013, 1828, 2026–2031. [CrossRef] [PubMed]
12. Wozniak, A.L.; Griffin, S.; Rowlands, D.; Harris, M.; Yi, M.; Lemon, S.M.; Weinman, S.A.
Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to
infectious virus production. PLoS Pathog. 2010, 6, e1001087. [CrossRef] [PubMed]
13. Steinmann, E.; Pietschmann, T. Hepatitis C virus p7-a viroporin crucial for virus assembly and an
emerging target for antiviral therapy. Viruses 2010, 2, 2078–2095. [CrossRef] [PubMed]
14. Madan, V.; Castello, A.; Carrasco, L. Viroporins from RNA viruses induce caspase-dependent
apoptosis. Cell. Microbiol. 2008, 10, 437–451. [CrossRef] [PubMed]
15. Bhowmick, R.; Halder, U.C.; Chattopadhyay, S.; Chanda, S.; Nandi, S.; Bagchi, P.; Nayak, M.K.;
Chakrabarti, O.; Kobayashi, N.; Chawla-Sarkar, M. Rotaviral enterotoxin nonstructural protein
4 targets mitochondria for activation of apoptosis during infection. J. Biol. Chem. 2012, 287,
35004–35020. [CrossRef] [PubMed]
16. Ichinohe, T.; Pang, I.K.; Iwasaki, A. Influenza virus activates inflammasomes via its intracellular
M2 ion channel. Nat. Immunol. 2010, 11, 404–410. [CrossRef] [PubMed]
17. Ito, M.; Yanagi, Y.; Ichinohe, T. Encephalomyocarditis virus viroporin 2B activates NLRP3
inflammasome. PLoS Pathog. 2012, 8, e1002857. [CrossRef] [PubMed]
Viruses 2015, 7 3566
18. Triantafilou, K.; Kar, S.; Vakakis, E.; Kotecha, S.; Triantafilou, M. Human respiratory syncytial
virus viroporin SH: A viral recognition pathway used by the host to signal inflammasome
activation. Thorax 2013, 68, 66–75. [CrossRef] [PubMed]
19. Triantafilou, K.; Kar, S.; van Kuppeveld, F.J.; Triantafilou, M. Rhinovirus-induced calcium flux
triggers NLRP3 and NLRC5 activation in bronchial cells. Am. J. Respir. Cell Mol. Biol. 2013.
[CrossRef] [PubMed]
20. McAuley, J.L.; Tate, M.D.; MacKenzie-Kludas, C.J.; Pinar, A.; Zeng, W.; Stutz, A.; Latz, E.;
Brown, L.E.; Mansell, A. Activation of the NLRP3 inflammasome by IAV virulence protein
PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog. 2013, 9, e1003392.
[CrossRef] [PubMed]
21. Zhang, K.; Hou, Q.; Zhong, Z.; Li, X.; Chen, H.; Li, W.; Wen, J.; Wang, L.; Liu, W.;
Zhong, F. Porcine reproductive and respiratory syndrome virus activates inflammasomes of
porcine alveolar macrophages via its small envelope protein E. Virology 2013, 442, 156–162.
[CrossRef] [PubMed]
22. Nieto-Torres, J.L.; Dediego, M.L.; Verdia-Baguena, C.; Jimenez-Guardeño, J.M.;
Regla-Nava, J.A.; Fernandez-Delgado, R.; Castaño-Rodriguez, C.; Alcaraz, A.; Torres, J.;
Aguilella, V.M.; et al. Severe acute respiratory syndrome coronavirus envelope protein ion
channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014, 10, e1004077.
[CrossRef] [PubMed]
23. Triantafilou, K.; Triantafilou, M. Ion flux in the lung: Virus-induced inflammasome activation.
Trends Microbiol. 2014, 22, 580–588. [CrossRef] [PubMed]
24. Wang, K.; Lu, W.; Chen, J.; Xie, S.; Shi, H.; Hsu, H.; Yu, W.; Xu, K.; Bian, C.; Fischer, W.B.; et al.
PEDV ORF3 encodes an ion channel protein and regulates virus production. FEBS Lett. 2012,
586, 384–391. [CrossRef] [PubMed]
25. Zhang, R.; Wang, K.; Lv, W.; Yu, W.; Xie, S.; Xu, K.; Schwarz, W.; Xiong, S.; Sun, B. The ORF4a
protein of human coronavirus 229E functions as a viroporin that regulates viral production.
Biochim. Biophys. Acta 2014. [CrossRef] [PubMed]
26. Lu, W.; Zheng, B.J.; Xu, K.; Schwarz, W.; Du, L.; Wong, C.K.; Chen, J.; Duan, S.; Deubel, V.;
Sun, B. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel
and modulates virus release. Proc. Natl. Acad. Sci. USA 2006, 103, 12540–12545. [CrossRef]
[PubMed]
27. Acharya, R.; Carnevale, V.; Fiorin, G.; Levine, B.G.; Polishchuk, A.L.; Balannik, V.; Samish, I.;
Lamb, R.A.; Pinto, L.H.; DeGrado, W.F.; et al. Structure and mechanism of proton transport
through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc. Natl.
Acad. Sci. USA 2010, 107, 15075–15080. [CrossRef] [PubMed]
28. Agirre, A.; Barco, A.; Carrasco, L.; Nieva, J.L. Viroporin-mediated membrane permeabilization.
Pore formation by nonstructural poliovirus 2B protein. J. Biol. Chem. 2002, 277, 40434–40441.
[CrossRef] [PubMed]
29. Plugge, B.; Gazzarrini, S.; Nelson, M.; Cerana, R.; Van Etten, J.L.; Derst, C.; DiFrancesco, D.;
Moroni, A.; Thiel, G. A potassium channel protein encoded by Chlorella virus PBCV-1. Science
2000, 287, 1641–1644. [CrossRef] [PubMed]
Viruses 2015, 7 3567
30. Shim, J.W.; Yang, M.; Gu, L.Q. In vitro synthesis, tetramerization and single channel
characterization of virus-encoded potassium channel Kcv. FEBS Lett. 2007, 581, 1027–1034.
[CrossRef] [PubMed]
31. Parthasarathy, K.; Ng, L.; Lin, X.; Liu, D.X.; Pervushin, K.; Gong, X.; Torres, J. Structural
flexibility of the pentameric SARS coronavirus envelope protein ion channel. Biophys. J. 2008,
95, 39–41. [CrossRef] [PubMed]
32. Pervushin, K.; Tan, E.; Parthasarathy, K.; Lin, X.; Jiang, F.L.; Yu, D.; Vararattanavech, A.;
Soong, T.W.; Liu, D.X.; Torres, J. Structure and inhibition of the SARS coronavirus envelope
protein ion channel. PLoS Pathog. 2009, 5, e1000511. [CrossRef] [PubMed]
33. Park, S.H.; Mrse, A.A.; Nevzorov, A.A.; Mesleh, M.F.; Oblatt-Montal, M.; Montal, M.;
Opella, S.J. Three-dimensional structure of the channel-forming trans-membrane domain of virus
protein “u” (Vpu) from HIV-1. J. Mol. Biol. 2003, 333, 409–424. [CrossRef] [PubMed]
34. Gan, S.W.; Ng, L.; Lin, X.; Gong, X.; Torres, J. Structure and ion channel activity of the
human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain.
Protein Sci. 2008, 17, 813–820. [CrossRef] [PubMed]
35. Luik, P.; Chew, C.; Aittoniemi, J.; Chang, J.; Wentworth, P., Jr.; Dwek, R.A.; Biggin, P.C.;
Venien-Bryan, C.; Zitzmann, N. The 3-dimensional structure of a hepatitis C virus p7 ion channel
by electron microscopy. Proc. Natl. Acad. Sci. USA 2009, 106, 12712–12716. [CrossRef]
[PubMed]
36. Wetherill, L.F.; Holmes, K.K.; Verow, M.; Muller, M.; Howell, G.; Harris, M.; Fishwick, C.;
Stonehouse, N.; Foster, R.; Blair, G.E.; et al. High-risk human papillomavirus E5 oncoprotein
displays channel-forming activity sensitive to small-molecule inhibitors. J. Virol. 2012, 86,
5341–5351. [CrossRef] [PubMed]
37. Tosteson, M.T.; Pinto, L.H.; Holsinger, L.J.; Lamb, R.A. Reconstitution of the influenza virus M2
ion channel in lipid bilayers. J. Membr. Biol. 1994, 142, 117–126. [CrossRef] [PubMed]
38. Marassi, F.M.; Ma, C.; Gratkowski, H.; Straus, S.K.; Strebel, K.; Oblatt-Montal, M.; Montal, M.;
Opella, S.J. Correlation of the structural and functional domains in the membrane protein vpu
from HIV-1. Proc. Natl. Acad. Sci USA 1999, 96, 14336–14341. [CrossRef] [PubMed]
39. Wang, C.; Lamb, R.A.; Pinto, L.H. Direct measurement of the influenza a virus M2 protein ion
channel activity in mammalian cells. Virology 1994, 205, 133–140. [CrossRef] [PubMed]
40. Vijayvergiya, V.; Wilson, R.; Chorak, A.; Gao, P.F.; Cross, T.A.; Busath, D.D. Proton conductance
of influenza virus M2 protein in planar lipid bilayers. Biophys. J. 2004, 87, 1697–1704.
[CrossRef] [PubMed]
41. Lin, T.I.; Schroeder, C. Definitive assignment of proton selectivity and attoampere unitary current
to the M2 ion channel protein of influenza A virus. J. Virol. 2001, 75, 3647–3656. [CrossRef]
[PubMed]
42. Premkumar, A.; Wilson, L.; Ewart, G.D.; Gage, P.W. Cation-selective ion channels formed by
p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett. 2004, 557, 99–103.
[CrossRef]
Viruses 2015, 7 3568
43. Li, Y.; To, J.; Verdia-Baguena, C.; Dossena, S.; Surya, W.; Huang, M.; Paulmichl, M.; Liu, D.X.;
Aguilella, V.M.; Torres, J. Inhibition of the human respiratory syncytial virus small hydrophobic
protein and structural variations in a bicelle environment. J. Virol. 2014, 88, 11899–11914.
[CrossRef] [PubMed]
44. Malev, V.V.; Schagina, L.V.; Gurnev, P.A.; Takemoto, J.Y.; Nestorovich, E.M.; Bezrukov, S.M.
Syringomycin e channel: A lipidic pore stabilized by lipopeptide? Biophys. J. 2002, 82,
1985–1994. [CrossRef]
45. Sobko, A.A.; Kotova, E.A.; Antonenko, Y.N.; Zakharov, S.D.; Cramer, W.A. Effect of lipids with
different spontaneous curvature on the channel activity of colicin E1: Evidence in favor of a
toroidal pore. FEBS Lett. 2004, 576, 205–210. [CrossRef] [PubMed]
46. Wang, C.; Lamb, R.A.; Pinto, L.H. Activation of the M2 ion channel of influenza virus: A role
for the transmembrane domain histidine residue. Biophys. J. 1995, 69, 1363–1371. [CrossRef]
47. Goldstein, D.J.; Schlegel, R. The E5 oncoprotein of bovine papillomavirus binds to a 16 kDa
cellular protein. EMBO J. 1990, 9, 137–145. [PubMed]
48. Andresson, T.; Sparkowski, J.; Goldstein, D.J.; Schlegel, R. Vacuolar H(+)-ATPase mutants
transform cells and define a binding site for the papillomavirus E5 oncoprotein. J. Biol. Chem.
1995, 270, 6830–6837. [PubMed]
49. Nieto-Torres, J.L.; DeDiego, M.L.; Alvarez, E.; Jimenez-Guardeño, J.M.; Regla-Nava, J.A.;
Llorente, M.; Kremer, L.; Shuo, S.; Enjuanes, L. Subcellular location and topology of severe
acute respiratory syndrome coronavirus envelope protein. Virology 2011, 415, 69–82. [CrossRef]
[PubMed]
50. Mi, S.; Li, Y.; Yan, J.; Gao, G.F. Na(+)/K (+)-ATPase beta1 subunit interacts with M2 proteins
of influenza A and B viruses and affects the virus replication. Sci. China Life Sci. 2010, 53,
1098–1105. [CrossRef] [PubMed]
51. Geering, K. Function of FXYD proteins, regulators of Na, K-ATPase. J. Bioenerg. Biomembr.
2005, 37, 387–392. [CrossRef] [PubMed]
52. Glaves, J.P.; Trieber, C.A.; Ceholski, D.K.; Stokes, D.L.; Young, H.S. Phosphorylation and
mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium
pump. J. Mol. Biol. 2011, 405, 707–723. [CrossRef] [PubMed]
53. Minor, N.T.; Sha, Q.; Nichols, C.G.; Mercer, R.W. The gamma subunit of the Na, K-ATPase
induces cation channel activity. Proc. Natl. Acad. Sci. USA 1998, 95, 6521–6525. [CrossRef]
[PubMed]
54. Hsu, K.; Seharaseyon, J.; Dong, P.; Bour, S.; Marban, E. Mutual functional destruction of HIV-1
Vpu and host Task-1 channel. Mol. Cell 2004, 14, 259–267. [CrossRef]
55. Lazrak, A.; Iles, K.E.; Liu, G.; Noah, D.L.; Noah, J.W.; Matalon, S. Influenza virus M2 protein
inhibits epithelial sodium channels by increasing reactive oxygen species. FASEB J. 2009, 23,
3829–3842. [CrossRef] [PubMed]
56. Ji, H.L.; Song, W.; Gao, Z.; Su, X.F.; Nie, H.G.; Jiang, Y.; Peng, J.B.; He, Y.X.; Liao, Y.;
Zhou, Y.J.; et al. SARS-CoV proteins decrease levels and activity of human ENaC via activation
of distinct PKC isoforms. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296, L372–L383.
[CrossRef] [PubMed]
Viruses 2015, 7 3569
57. Steinmann, E.; Penin, F.; Kallis, S.; Patel, A.H.; Bartenschlager, R.; Pietschmann, T. Hepatitis C
virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog. 2007, 3,
e103. [CrossRef] [PubMed]
58. Cheung, T.K.; Guan, Y.; Ng, S.S.; Chen, H.; Wong, C.H.; Peiris, J.S.; Poon, L.L. Generation of
recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation
at the 51 end of the viral intron. J. Gen. Virol. 2005, 86, 1447–1454. [CrossRef] [PubMed]
59. Strebel, K.; Klimkait, T.; Martin, M.A. A novel gene of HIV-1, Vpu, and its 16-kilodalton product.
Science 1988, 241, 1221–1223. [CrossRef] [PubMed]
60. Ortego, J.; Escors, D.; Laude, H.; Enjuanes, L. Generation of a replication-competent,
propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome.
J. Virol. 2002, 76, 11518–11529. [CrossRef] [PubMed]
61. Almazan, F.; DeDiego, M.L.; Sola, I.; Zuñiga, S.; Nieto-Torres, J.L.; Marquez-Jurado, S.;
Andres, G.; Enjuanes, L. Engineering a replication-competent, propagation-defective Middle East
respiratory syndrome coronavirus as a vaccine candidate. mBio 2013, 4, e00650-13. [CrossRef]
[PubMed]
62. DeDiego, M.L.; Alvarez, E.; Almazan, F.; Rejas, M.T.; Lamirande, E.; Roberts, A.; Shieh, W.J.;
Zaki, S.R.; Subbarao, K.; Enjuanes, L. A severe acute respiratory syndrome coronavirus that lacks
the E gene is attenuated in vitro and in vivo. J. Virol. 2007, 81, 1701–1713. [CrossRef] [PubMed]
63. Kuo, L.; Masters, P.S. The small envelope protein E is not essential for murine coronavirus
replication. J. Virol. 2003, 77, 4597–4608. [CrossRef] [PubMed]
64. Akerstrom, S.; Mirazimi, A.; Tan, Y.J. Inhibition of SARS-CoV replication cycle by small
interference rnas silencing specific SARS proteins, 7a/7b, 3a/3b and S. Antivir. Res. 2007, 73,
219–227. [CrossRef] [PubMed]
65. Bukreyev, A.; Whitehead, S.S.; Murphy, B.R.; Collins, P.L. Recombinant respiratory syncytial
virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits
site-specific attenuation in the respiratory tract of the mouse. J. Virol. 1997, 71, 8973–8982.
[PubMed]
66. Whitehead, S.S.; Bukreyev, A.; Teng, M.N.; Firestone, C.Y.; St Claire, M.; Elkins, W.R.;
Collins, P.L.; Murphy, B.R. Recombinant respiratory syncytial virus bearing a deletion of either
the NS2 or SH gene is attenuated in chimpanzees. J. Virol. 1999, 73, 3438–3442. [PubMed]
67. Corse, E.; Machamer, C.E. The cytoplasmic tails of infectious bronchitis virus E and M proteins
mediate their interaction. Virology 2003, 312, 25–34. [CrossRef]
68. Jimenez-Guardeño, J.M.; Nieto-Torres, J.L.; DeDiego, M.L.; Regla-Nava, J.A.;
Fernandez-Delgado, R.; Castaño-Rodriguez, C.; Enjuanes, L. The PDZ-binding motif of
severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral
pathogenesis. PLoS Pathog. 2014, 10, e1004320. [CrossRef] [PubMed]
69. Chen, B.J.; Leser, G.P.; Jackson, D.; Lamb, R.A. The influenza virus M2 protein cytoplasmic tail
interacts with the M1 protein and influences virus assembly at the site of virus budding. J. Virol.
2008, 82, 10059–10070. [CrossRef] [PubMed]
70. Rossman, J.S.; Jing, X.; Leser, G.P.; Lamb, R.A. Influenza virus M2 protein mediates
ESCRT-independent membrane scission. Cell 2010, 142, 902–913. [CrossRef] [PubMed]
Viruses 2015, 7 3570
71. Neil, S.J.; Zang, T.; Bieniasz, P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1
Vpu. Nature 2008, 451, 425–430. [CrossRef] [PubMed]
72. Van Damme, N.; Goff, D.; Katsura, C.; Jorgenson, R.L.; Mitchell, R.; Johnson, M.C.;
Stephens, E.B.; Guatelli, J. The interferon-induced protein BST-2 restricts HIV-1 release and
is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3,
245–252. [CrossRef] [PubMed]
73. Bolduan, S.; Votteler, J.; Lodermeyer, V.; Greiner, T.; Koppensteiner, H.; Schindler, M.; Thiel, G.;
Schubert, U. Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317.
Virology 2011, 416, 75–85. [CrossRef] [PubMed]
74. Takeda, M.; Pekosz, A.; Shuck, K.; Pinto, L.H.; Lamb, R.A. Influenza A virus M2 ion channel
activity is essential for efficient replication in tissue culture. J. Virol. 2002, 76, 1391–1399.
[CrossRef] [PubMed]
75. Watanabe, T.; Watanabe, S.; Ito, H.; Kida, H.; Kawaoka, Y. Influenza A virus can undergo multiple
cycles of replication without M2 ion channel activity. J. Virol. 2001, 75, 5656–5662. [CrossRef]
[PubMed]
76. Schubert, U.; Ferrer-Montiel, A.V.; Oblatt-Montal, M.; Henklein, P.; Strebel, K.; Montal, M.
Identification of an ion channel activity of the Vpu transmembrane domain and its involvement
in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 1996, 398, 12–18.
[CrossRef]
77. Grambas, S.; Bennett, M.S.; Hay, A.J. Influence of amantadine resistance mutations on the pH
regulatory function of the M2 protein of influenza A viruses. Virology 1992, 191, 541–549.
[CrossRef]
78. Wilson, L.; Gage, P.; Ewart, G. Hexamethylene amiloride blocks E protein ion channels and
inhibits coronavirus replication. Virology 2006, 353, 294–306. [CrossRef] [PubMed]
79. Zebedee, S.L.; Lamb, R.A. Influenza A virus M2 protein: Monoclonal antibody restriction of
virus growth and detection of M2 in virions. J. Virol. 1988, 62, 2762–2772. [PubMed]
80. Maeda, J.; Repass, J.F.; Maeda, A.; Makino, S. Membrane topology of coronavirus E protein.
Virology 2001, 281, 163–169. [CrossRef] [PubMed]
81. Raamsman, M.J.B.; Locker, J.K.; de Hooge, A.; de Vries, A.A.F.; Griffiths, G.; Vennema, H.;
Rottier, P.J.M. Characterization of the coronavirus mouse hepatitis virus strain A59 small
membrane protein E. J. Virol. 2000, 74, 2333–2342. [CrossRef] [PubMed]
82. Wharton, S.A.; Belshe, R.B.; Skehel, J.J.; Hay, A.J. Role of virion M2 protein in influenza virus
uncoating: Specific reduction in the rate of membrane fusion between virus and liposomes by
amantadine. J. Gen. Virol. 1994, 75, 945–948. [CrossRef] [PubMed]
83. Bullough, P.A.; Hughson, F.M.; Skehel, J.J.; Wiley, D.C. Structure of influenza haemagglutinin at
the pH of membrane fusion. Nature 1994, 371, 37–43. [CrossRef] [PubMed]
84. Stauffer, S.; Feng, Y.; Nebioglu, F.; Heilig, R.; Picotti, P.; Helenius, A. Stepwise priming by acidic
pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after
penetration. J. Virol. 2014, 88, 13029–13046. [CrossRef] [PubMed]
Viruses 2015, 7 3571
85. Nakamura, N.; Tanaka, S.; Teko, Y.; Mitsui, K.; Kanazawa, H. Four Na+/H+ exchanger isoforms
are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation.
J. Biol. Chem. 2005, 280, 1561–1572. [CrossRef] [PubMed]
86. Sakaguchi, T.; Leser, G.P.; Lamb, R.A. The ion channel activity of the influenza virus M2 protein
affects transport through the Golgi apparatus. J. Cell Biol. 1996, 133, 733–747. [CrossRef]
[PubMed]
87. Ruch, T.R.; Machamer, C.E. A single polar residue and distinct membrane topologies impact the
function of the infectious bronchitis coronavirus E protein. PLoS Pathog. 2012, 8, e1002674.
[CrossRef] [PubMed]
88. De Jong, A.S.; de Mattia, F.; van Dommelen, M.M.; Lanke, K.; Melchers, W.J.; Willems, P.H.; van
Kuppeveld, F.J. Functional analysis of picornavirus 2B proteins: Effects on calcium homeostasis
and intracellular protein trafficking. J. Virol. 2008, 82, 3782–3790. [CrossRef] [PubMed]
89. Freundt, E.C.; Yu, L.; Goldsmith, C.S.; Welsh, S.; Cheng, A.; Yount, B.; Liu, W.; Frieman, M.B.;
Buchholz, U.J.; Screaton, G.R.; et al. The open reading frame 3a protein of severe acute
respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.
J. Virol. 2010, 84, 1097–1109. [CrossRef] [PubMed]
90. Crawford, S.E.; Hyser, J.M.; Utama, B.; Estes, M.K. Autophagy hijacked through
viroporin-activated calcium/calmodulin-dependent kinase kinase-beta signaling is required for
rotavirus replication. Proc. Natl. Acad. Sci. USA 2012, 109, E3405–E3413. [CrossRef]
[PubMed]
91. Anderson, R.G.; Orci, L. A view of acidic intracellular compartments. J. Cell Biol. 1988, 106,
539–543. [CrossRef] [PubMed]
92. Takeuchi, K.; Lamb, R.A. Influenza virus M2 protein ion channel activity stabilizes the native
form of fowl plague virus hemagglutinin during intracellular transport. J. Virol. 1994, 68,
911–919. [PubMed]
93. Watanabe, S.; Watanabe, T.; Kawaoka, Y. Influenza A virus lacking M2 protein as a live attenuated
vaccine. J. Virol. 2009, 83, 5947–5950. [CrossRef] [PubMed]
94. Gladue, D.P.; Holinka, L.G.; Largo, E.; Fernandez Sainz, I.; Carrillo, C.; O’Donnell, V.;
Baker-Branstetter, R.; Lu, Z.; Ambroggio, X.; Risatti, G.R.; et al. Classical swine fever virus p7
protein is a viroporin involved in virulence in swine. J. Virol. 2012, 86, 6778–6791. [CrossRef]
[PubMed]
95. DeDiego, M.L.; Nieto-Torres, J.L.; Jimenez-Guardeño, J.M.; Regla-Nava, J.A.; Alvarez, E.;
Oliveros, J.C.; Zhao, J.; Fett, C.; Perlman, S.; Enjuanes, L. Severe acute respiratory syndrome
coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog. 2011, 7,
e1002315. [CrossRef] [PubMed]
96. DeDiego, M.L.; Nieto-Torres, J.L.; Regla-Nava, J.A.; Jimenez-Guardeño, J.M.;
Fernandez-Delgado, R.; Fett, C.; Castaño-Rodriguez, C.; Perlman, S.; Enjuanes, L. Inhibition
of NF-kappaB mediated inflammation in severe acute respiratory syndome coronavirus-infected
mice increases survival. J. Virol. 2014, 88, 913–924. [CrossRef] [PubMed]
Viruses 2015, 7 3572
97. Regla-Nava, J.A.; Nieto-Torres, J.L.; Jimenez-Guardeño, J.M.; Fernandez-Delgado, R.; Fett, C.;
Castaño-Rodriguez, C.; Perlman, S.; Enjuanes, L.; DeDiego, M.L. SARS coronaviruses with
mutations in E protein are attenuated and promising vaccine candidates. J. Virol. 2015, 89,
3870–3887. [CrossRef] [PubMed]
98. Obitsu, S.; Ahmed, N.; Nishitsuji, H.; Hasegawa, A.; Nakahama, K.; Morita, I.; Nishigaki, K.;
Hayashi, T.; Masuda, T.; Kannagi, M. Potential enhancement of osteoclastogenesis by severe
acute respiratory syndrome coronavirus 3a/X1 protein. Arch. Virol. 2009, 154, 1457–1464.
[CrossRef] [PubMed]
99. Kanzawa, N.; Nishigaki, K.; Hayashi, T.; Ishii, Y.; Furukawa, S.; Niiro, A.; Yasui, F.; Kohara, M.;
Morita, K.; Matsushima, K.; et al. Augmentation of chemokine production by severe acute
respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.
FEBS Lett. 2006, 580, 6807–6812. [CrossRef] [PubMed]
100. Narayanan, K.; Huang, C.; Makino, S. SARS coronavirus accessory proteins. Virus Res. 2008,
133, 113–121. [CrossRef] [PubMed]
101. Wong, S.L.; Chen, Y.; Chan, C.M.; Chan, C.S.; Chan, P.K.; Chui, Y.L.; Fung, K.P.; Waye, M.M.;
Tsui, S.K.; Chan, H.Y. In vivo functional characterization of the SARS-coronavirus 3a protein in
drosophila. Biochem. Biophys. Res. Commun. 2005, 337, 720–729. [CrossRef] [PubMed]
102. Cornell, C.T.; Kiosses, W.B.; Harkins, S.; Whitton, J.L. Coxsackievirus B3 proteins directionally
complement each other to downregulate surface major histocompatibility complex class I. J. Virol.
2007, 81, 6785–6797. [CrossRef] [PubMed]
103. Matthay, M.A.; Zemans, R.L. The acute respiratory distress syndrome: Pathogenesis and
treatment. Annu. Rev. Pathol. 2011, 6, 147–163. [CrossRef] [PubMed]
104. Pugin, J.; Ricou, B.; Steinberg, K.P.; Suter, P.M.; Martin, T.R. Proinflammatory activity in
bronchoalveolar lavage fluids from patients with ards, a prominent role for interleukin-1. Am. J.
Respir. Crit. Care Med. 1996, 153, 1850–1856. [CrossRef] [PubMed]
105. Grommes, J.; Soehnlein, O. Contribution of neutrophils to acute lung injury. Mol. Med. 2011, 17,
293–307. [CrossRef] [PubMed]
106. dos Santos, G.; Kutuzov, M.A.; Ridge, K.M. The inflammasome in lung diseases. Am. J. Physiol.
Lung Cell. Mol. Physiol. 2012, 303, L627–L633. [CrossRef] [PubMed]
107. Strowig, T.; Henao-Mejia, J.; Elinav, E.; Flavell, R. Inflammasomes in health and disease. Nature
2012, 481, 278–286. [CrossRef] [PubMed]
108. Murakami, T.; Ockinger, J.; Yu, J.; Byles, V.; McColl, A.; Hofer, A.M.; Horng, T. Critical role
for calcium mobilization in activation of the NLRP3 inflammasome. Proc. Natl. Acad. Sci. USA
2012, 109, 11282–11287. [CrossRef] [PubMed]
109. Munoz-Planillo, R.; Kuffa, P.; Martinez-Colon, G.; Smith, B.L.; Rajendiran, T.M.; Nunez, G.
K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and
particulate matter. Immunity 2013, 38, 1142–1153. [CrossRef] [PubMed]
110. Elliott, E.I.; Sutterwala, F.S. Initiation and perpetuation of NLRP3 inflammasome activation and
assembly. Immunol. Rev. 2015, 265, 35–52. [CrossRef] [PubMed]
Viruses 2015, 7 3573
111. Shrivastava, S.; Mukherjee, A.; Ray, R.; Ray, R.B. Hepatitis C virus induces interleukin-1beta
(IL-1beta)/IL-18 in circulatory and resident liver macrophages. J. Virol. 2013, 87, 12284–12290.
[CrossRef] [PubMed]
112. Griffin, S.D.; Beales, L.P.; Clarke, D.S.; Worsfold, O.; Evans, S.D.; Jaeger, J.; Harris, M.P.;
Rowlands, D.J. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the
antiviral drug, amantadine. FEBS Lett. 2003, 535, 34–38. [CrossRef]
113. Oxford, J.S. Antivirals for the treatment and prevention of epidemic and pandemic influenza.
Influenza Other Respir. Viruses 2007, 1, 27–34. [CrossRef] [PubMed]
114. Ewart, G.D.; Mills, K.; Cox, G.B.; Gage, P.W. Amiloride derivatives block ion channel activity
and enhancement of virus-like particle budding caused by HIV-1 protein Vpu. Eur. Biophys. J.
2002, 31, 26–35. [CrossRef] [PubMed]
115. Cady, S.D.; Schmidt-Rohr, K.; Wang, J.; Soto, C.S.; Degrado, W.F.; Hong, M. Structure of the
amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 2010, 463,
689–692. [CrossRef] [PubMed]
116. Govorkova, E.A.; Webster, R.G. Combination chemotherapy for influenza. Viruses 2010, 2,
1510–1529. [CrossRef] [PubMed]
117. Griffin, S.; Stgelais, C.; Owsianka, A.M.; Patel, A.H.; Rowlands, D.; Harris, M.
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Hepatology 2008, 48, 1779–1790. [CrossRef] [PubMed]
118. Luscombe, C.A.; Huang, Z.; Murray, M.G.; Miller, M.; Wilkinson, J.; Ewart, G.D. A novel
hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and
shows synergism with recombinant interferon-alpha-2b and nucleoside analogues. Antivir. Res.
2010, 86, 144–153. [CrossRef] [PubMed]
119. Coll, R.C.; Robertson, A.A.; Chae, J.J.; Higgins, S.C.; Munoz-Planillo, R.; Inserra, M.C.;
Vetter, I.; Dungan, L.S.; Monks, B.G.; Stutz, A.; et al. A small-molecule inhibitor of the NLRP3
inflammasome for the treatment of inflammatory diseases. Nat. Med. 2015, 21, 248–255.
[PubMed]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/4.0/).
